Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Thompson

Showing results (411-420 of 569) with videos related to

Pageof 57
Sort By:
Oncotarget|June 11, 2014
A highly recurrent RPS27 5'UTR mutation in melanomaKen Dutton-Regester, Jared J Gartner, Rafi Emmanuel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
An analysis of the association between serum citrulline and acute rejection among 26 recipients of intestinal transplantPeter A Pappas, Andreas G Tzakis, Jeffrey J Gaynor, et al.
Annals of Surgery|June 4, 2008
False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathologyRooshdiya Z Karim, Richard A Scolyer, Wei Li, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 18, 2020
Primary dermal melanoma: clinical behaviour, prognosis and treatmentChristopher G Harris, Serigne Lo, Tasnia Ahmed, et al.
Neuro-Oncology|June 28, 2014
DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterationsDiego M Marzese, Richard A Scolyer, Maria Roqué, et al.
The American Journal of Surgical Pathology|December 6, 2003
Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomasRichard A Scolyer, Helen M Shaw, John F Thompson, et al.
Cancer|August 12, 2020
Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging systemMohammed Kashani-Sabet, James R Miller, Serigne Lo, et al.
Pathology|March 30, 2016
The molecular profile of metastatic melanoma in AustraliaMegan Lyle, Lauren E Haydu, Alexander M Menzies, et al.
BMC Research Notes|May 9, 2015
First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data qualityGerald B Fogarty, Angela Hong, Kari Dolven-Jacobsen, et al.
The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.
Pageof 57

Showing results (411-420 of 569) with videos related to

Sort By:
Pageof 57
Oncotarget|June 11, 2014
A highly recurrent RPS27 5'UTR mutation in melanomaKen Dutton-Regester, Jared J Gartner, Rafi Emmanuel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
An analysis of the association between serum citrulline and acute rejection among 26 recipients of intestinal transplantPeter A Pappas, Andreas G Tzakis, Jeffrey J Gaynor, et al.
Annals of Surgery|June 4, 2008
False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathologyRooshdiya Z Karim, Richard A Scolyer, Wei Li, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 18, 2020
Primary dermal melanoma: clinical behaviour, prognosis and treatmentChristopher G Harris, Serigne Lo, Tasnia Ahmed, et al.
Neuro-Oncology|June 28, 2014
DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterationsDiego M Marzese, Richard A Scolyer, Maria Roqué, et al.
The American Journal of Surgical Pathology|December 6, 2003
Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomasRichard A Scolyer, Helen M Shaw, John F Thompson, et al.
Cancer|August 12, 2020
Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging systemMohammed Kashani-Sabet, James R Miller, Serigne Lo, et al.
Pathology|March 30, 2016
The molecular profile of metastatic melanoma in AustraliaMegan Lyle, Lauren E Haydu, Alexander M Menzies, et al.
BMC Research Notes|May 9, 2015
First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data qualityGerald B Fogarty, Angela Hong, Kari Dolven-Jacobsen, et al.
The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.
Pageof 57